Viewing Study NCT00434356


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:15 PM
Study NCT ID: NCT00434356
Status: TERMINATED
Last Update Posted: 2009-12-03
First Post: 2007-02-09
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)
Sponsor: Genentech, Inc.
Organization: